Evidence map›Paper›PMID 32158432›Full record

ArticleFrontiers in endocrinology2020

Development and Psychometric Evaluation of an Instrument Assessing Barriers to Growth Hormone Treatment (BAR-GHT).

Martina de Zwaan, Josefine Fischer-Jacobs, Martin Wabitsch, Thomas Reinehr, Stefanie Meckes-Ferber, Ross D Crosby

Open access · goldAbstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Martina de ZwaanDepartment of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hanover, Germany.
Josefine Fischer-JacobsDepartment of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hanover, Germany.
Martin WabitschDivision of Pediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, University Medical Center, Ulm, Germany.
Thomas ReinehrVestische Kinder- und Jugendklinik Datteln, University Witten/Herdecke, Datteln, Germany.
Stefanie Meckes-FerberClinical, Medical and Regulatory Department, Novo Nordisk Pharma GmbH, Mainz, Germany.
Ross D CrosbyCenter for Biobehavioral Research, Sanford Health, Fargo, ND, United States.
Medizinische Hochschule Hannover · DENovo Nordisk (Germany) · DESanford Health · USVestische Caritas-Kliniken · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Patient Reported Outcome MeasuresPsychometricsQuality of LifeAdolescentChildChild, PreschoolFemaleFollow-Up StudiesGrowth DisordersHuman Growth HormoneHumansInfantInfant, NewbornMalePrognosisSurveys and QuestionnairesHuman Growth Hormoneadherencebarriersfactor analysisgrowth hormone therapypatient reported outcome measure

Identifiers

PMID32158432
PMCPMC7051941
OpenAlexW3006908393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.